Attention-deficit/hyperactivity disorder.
Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, Newcorn JH, Philipsen A, Polanczyk GV, Rubia K, Sibley MH, Buitelaar JK.
Nat Rev Dis Primers. 2024 Feb 22;10(1):11. doi: 10.1038/s41572-024-00495-0.
Attention-Deficit/Hyperactivity Disorder: A Historical Neuropsychological Perspective.
Mahone EM, Denckla MB.
J Int Neuropsychol Soc. 2017 Oct;23(9-10):916-929. doi: 10.1017/S1355617717000807.
Attention-deficit hyperactivity disorder.
Biederman J, Faraone SV.
Lancet. 2005 Jul 16-22;366(9481):237-48. doi: 10.1016/S0140-6736(05)66915-2.
[Cognitive deficit in children with hyperkinetic disorder].
Gasanov RF, Makarov IV, Emelina DA.
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(3):126-131. doi: 10.17116/jnevro2020120031126.
Hyperkinetic disorder in a community service for people with intellectual disability.
Patel S, Yacoub E.
Ir J Psychol Med. 2021 Sep;38(3):177-181. doi: 10.1017/ipm.2018.39. Epub 2018 Oct 3.
The worldwide prevalence of ADHD: a systematic review and metaregression analysis.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA.
Am J Psychiatry. 2007 Jun;164(6):942-8. doi: 10.1176/ajp.2007.164.6.942.
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
Pliszka S; AACAP Work Group on Quality Issues.
J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. doi: 10.1097/chi.0b013e318054e724.
Classics in Chemical Neuroscience: Methylphenidate.
Wenthur CJ.
ACS Chem Neurosci. 2016 Aug 17;7(8):1030-40. doi: 10.1021/acschemneuro.6b00199. Epub 2016 Jul 25.
Hyperkinetic or attention deficit disorder.
Sandberg S.
Br J Psychiatry. 1996 Jul;169(1):10-7. doi: 10.1192/bjp.169.1.10.
Attention-deficit hyperactivity disorder and hyperkinetic disorder.
Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP.
Lancet. 1998 Feb 7;351(9100):429-33.
